CogState

CogState CapEx Growth

The Year-over-Year CapEx Growth of CogState (CGS.AX) as of Oct 17, 2026 is 62.79 %. In the previous year, Year-over-Year CapEx Growth was -14.57 % — a change of -531.02% (higher).

CapEx Growth

62.79 %

YoY

-531.02%

Last updated:

Year-over-Year CapEx Growth of CogState is 2025 62.79 % . Year-over-Year CapEx Growth of CogState was 2024 -14.57 % . It decreases by -531.02% higher compared to the previous year.

The CogState CapEx Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx Growth
Date
CapEx Growth
Jan 1, 2018
160.16 USD
Jan 1, 2019
-14.85 USD
Jan 1, 2020
28.55 USD
Jan 1, 2021
3.83 USD
Jan 1, 2022
9.36 USD
Jan 1, 2023
-37.93 USD
Jan 1, 2024
-14.57 USD
Jan 1, 2025
62.79 USD
The CogState CapEx Growth history
YEARCapEx GrowthYoY
62.79 %-531.02%
-14.57 %-61.60%
-37.93 %-505.28%
9.36 %+144.43%
3.83 %-86.59%
28.55 %-292.27%
-14.85 %-109.27%
160.16 %-5,932.19%
-2.75 %-104.35%
63.09 %-951.04%
-7.41 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CogState Stock analysis

What does CogState do? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CogState stock

Year-over-Year CapEx Growth of CogState is 62.79 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year CapEx Growth CogState since 2006 – with annual values, charts, and detailed analysis.

CapEx growth measures the percentage change in capital expenditures. Increasing CapEx can signal investment in future growth capacity.

To evaluate Year-over-Year CapEx Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year CapEx Growth.

Year-over-Year CapEx Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year CapEx Growth's CogState historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — CogState

All Key Metrics — CogState